One-year consolidation with Ponatinib 15 mg in chronic myeloid leukaemia on deep molecular response with Imatinib Ann Hematol
Red blood cell immunization as an independent predictor of survival in the myelodysplastic syndromes BRIT J HAEMATOL
EASIX, a new tool to predict response and refractoriness in immune-mediated thrombotic thrombocytopenic purpura Front Immunol
Immunosuppressive macrophages determine the effect of cellular senescence on tumor progression Sci Adv
HCT Pre-App Program: A Telemedicine-based Prehabilitation for Allogeneic Hematopoietic Cell Transplant candidates Blood Adv
Cilta-cel in lenalidomide-refractory multiple myeloma (CARTITUDE-4): an updated analysis including overall survival from an open-label, multicentre, randomised, phase 3 trial Lancet Oncol
CEBPA-bZIP Mutations in AML Patients Treated With Non-Intensive Therapy: A Study by the Spanish PETHEMA Registry Hematol Oncol
Dual FLT3/PIM inhibitor dapolsertib in acute myeloid leukemia: results from the phase 1/2 DIAMOND-01 trial Blood Neoplasia
Angiogenic factor levels across severity stages of fetal smallness with or without associated pre-eclampsia ULTRASOUND OBST GYN